David H. Barlow, PhD; Todd J. Farchione, PhD; Jacqueline R. Bullis, PhD; et al.
free access
JAMA Psychiatry. 2017;74(9):875-884. doi:10.1001/jamapsychiatry.2017.2164
This randomized clinical equivalence trial examines whether the Unified Protocol is at least as efficacious as single-disorder protocols in the treatment of anxiety disorders.
Kelly E. Dunn, PhD; D. Andrew Tompkins, MD, MHS; George E. Bigelow, PhD; et al.
free access
has audio
JAMA Psychiatry. 2017;74(9):885-893. doi:10.1001/jamapsychiatry.2017.1838
This randomized clinical trial compares the use of tramadol extended-release with clonidine and buprenorphine in treatment of withdrawal symptoms in patients with opioid use disorder.
-
Podcast:
Tramadol Extended-Release for Opioid Withdrawal
Sharon L. Walsh, PhD; Sandra D. Comer, PhD; Michelle R. Lofwall, MD; et al.
free access
JAMA Psychiatry. 2017;74(9):894-902. doi:10.1001/jamapsychiatry.2017.1874
This randomized clinical trial evaluates the ability of a novel subcutaneous buprenorphine depot formulation (CAM2038) to block euphorigenic opioid effects and suppress opioid withdrawal in nontreatment-seeking individuals with opioid use disorder.
James I. Hudson, MD, ScD; Susan L. McElroy, MD; M. Celeste Ferreira-Cornwell, PhD; et al.
open access
JAMA Psychiatry. 2017;74(9):903-910. doi:10.1001/jamapsychiatry.2017.1889
This randomized clinical trial evaluates the maintenance of efficacy of lisdexamfetamine dimesylate vs placebo after withdrawal in binge-eating disorder.
Bridget F. Grant, PhD; S. Patricia Chou, PhD; Tulshi D. Saha, PhD; et al.
free access
JAMA Psychiatry. 2017;74(9):911-923. doi:10.1001/jamapsychiatry.2017.2161
This study presents findings from interviews conducted in 2 US national surveys and reports changes in the prevalences of 12-month alcohol use, high-risk drinking, DSM-IV alcohol use disorder between 2001-2002 and 2012-2013.
-
Editorial
Remarkable Increases in Alcohol Use Disorders
Marc A. Schuckit, MD
JAMA Psychiatry
Robert J. Ursano, MD; Ronald C. Kessler, PhD; James A. Naifeh, PhD; et al.
free access
JAMA Psychiatry. 2017;74(9):924-931. doi:10.1001/jamapsychiatry.2017.1925
This cohort study examines whether a US Army soldier鈥檚 suicide attempt risk is associated with previous suicide attempts in that soldier鈥檚 unit.
Bastian Ravesteijn, PhD; Eli B. Schachar, JD; Aartjan T. F. Beekman, PhD; et al.
open access
JAMA Psychiatry. 2017;74(9):932-939. doi:10.1001/jamapsychiatry.2017.1847
This study examines the association of higher patient cost sharing with mental health care use and downstream effects, such as involuntary commitment and acute mental health care use.
Jennifer L. Skeem, PhD; Sarah Manchak, PhD; Lina Montoya, MA
free access
JAMA Psychiatry. 2017;74(9):942-948. doi:10.1001/jamapsychiatry.2017.1384
This longitudinal study assesses whether specialty probation yields better public safety outcomes than traditional probation for individuals with mental illness.
Edda Bilek, PhD; Gabriela Stößel, PhD; Axel Schäfer, PhD; et al.
free access
JAMA Psychiatry. 2017;74(9):949-957. doi:10.1001/jamapsychiatry.2017.1682
This cohort study applies recent advancements in the investigation of 2-person human social interaction to examine interaction difficulties among people with borderline personality disorder.
Peter Kochunov, PhD; Thomas R. Coyle, PhD; Laura M. Rowland, PhD; et al.
free access
JAMA Psychiatry. 2017;74(9):958-966. doi:10.1001/jamapsychiatry.2017.2228
This cross-sectional study uses a large sample of patients with schizophrenia and healthy controls to determine the association of white matter with information processing speed and working memory.